RUNX3 and laryngeal carcinoma: Xu et al30 also reported that the loss of RUNX3 expression was correlated with the upregulation of miR‐106b‐5p in human laryngeal carcinoma tissues, and miR‐106b promoted the viability and invasion of laryngeal carcinoma cells by directly targeting RUNX3.